Associations between α-tocopherol, β-carotene, and retinol and prostate cancer survival

Cancer Research

Volumn 69, Issue 9, 2009, Pages 3833-3841

  Watters, Joanne L ^a   Gail, Mitchell H ^a   Weinstein, Stephanie J ^a   Virtamo, Jarmo ^b   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; PLACEBO; RETINOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SURVIVAL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FAMILY HISTORY; FINLAND; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGED; ALPHA-TOCOPHEROL; BETA CAROTENE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; VITAMIN A;

EID: 65949087685     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4640     Document Type: Article

References (46)

1. Jemal A. Siegel R. Ward E. et al. Cancer Statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Signorello LB. Adami H-O. Prostate Cancer. In: Adami H-O. Hunter D. Trichopoulos D. editors. Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2002.
3. Sequoia JSP. Wright ME. McCarron P. et al. A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 2174-8.
4. Montgomery RB. Goldman B. Tangen CM. et al. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group Trials 8894 and 9916. J Urol 2007; 178: 1946-51.
5. Shimizu H. Ross R. Bernstein L. et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963-6.
6. Ries L. Melbert D. Krapcho M. et al. SEER Cancer Statistics Review, 1975-2004. Bethesda (MD): National Cancer Institute; 2007.
7. Wright ME. Weinstein SJ. Lawson KA. et al. Supplemental and dietary vitamin e intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1128-35.
8. Weinstein SJ. Wright ME. Lawson KA. et al. Serum and dietary vitamin e in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 1253-9.
9. Key TJ. Appleby PN. Allen NE. et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 2007; 86: 672-81.
10. Kirsh VA. Hayes RB. Mayne ST. et al. Supplemental and dietary vitamin e, β-carotene, and vitamin c intakes and prostate cancer risk. J Natl Cancer Inst 2006; 98: 245-54.
11. Kenfield S. Chang S. Chan Chan. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol 2007; 8: 173-96.
12. Demark-Wahnefried W. Moyad Moyad. Dietary intervention in the management of prostate cancer. Curr Opin Urol 2007; 17: 168-74.
13. Berkow Berkow. Barnard Barnard. Saxe Saxe. Ankerberg-Nobis T. Diet and survival after prostate cancer diagnosis. Nutr Rev 2007; 65: 391-403.
14. Chan Chan. Holick Holick. Leitzmann Leitzmann. et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 2006; 17: 199-208.
15. National Academy of Sciences (NAS) IoM. Dietary References Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and on Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on Scientific Evaluation of Dietary Reference Intakes. Washington (DC): National Academy Press; 2001.
16. Omenn Omenn. Micronutrients (vitamins and minerals) as cancer-preventive agents. IARC Sci Publ 1996; 139: 33-45.
17. The α-Tocophero β Carotene Cancer Prevention Study Group. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
18. Korhonen Korhonen. Malila Malila. Pukkala Pukkala. et al. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002; 41: 381-8.
19. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: J. B. Lippincott Company; 1992.
20. Heinonen Heinonen. Albanes Albanes. Virtamo Virtamo. et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90: 440-6.
21. The ATBC Cancer Prevention Study Group. The α-tocopherol, β-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10.
22. Milne Milne. Botnen Botnen. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986; 32: 874-6.
23. Kattermann Kattermann. Jaworek Jaworek. Möller G. et al. Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 1984; 22: 245-51.
24. Willett Willett. Nutritional epidemiology. New York (NY): Oxford University Press; 1998.
25. The ATBC Study Group. Incidence of cancer and mortality following {α}-tocopherol and {β}-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476-85.
26. Gaziano Gaziano. Glynn Glynn. Christen Christen. et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II Randomized Controlled Trial. JAMA 2009; 301: 52-62.
27. Lippman Lippman. Klein Klein. Goodman Goodman. et al. Effect of Selenium and vitamin E on Risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
28. Gogos Gogos. Ginopoulos Ginopoulos. Salsa Salsa. et al. Dietary ω-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer 1998; 82: 395-402.
29. Ornish Ornish. Weidner Weidner. Fair Fair. et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005; 174: 1065-70.
30. Bjelakovic Bjelakovic. Nikolova Nikolova. Gluud Gluud. Simonetti Simonetti. Gluud Gluud. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008; 16: CD007176.
31. Wright Wright. Lawson Lawson. Weinstein Weinstein. et al. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the α-Tocopherol, β-Carotene Cancer Prevention Study. Am J Clin Nutr 2006; 84: 1200-7.
32. Chan Chan. Gann Gann. Giovannucci Giovannucci. Role of diet in prostate cancer development and progression. J Clin Oncol 2005; 23: 8152-60.
33. Venkateswaran Venkateswaran. Fleshner Fleshner. Klotz Klotz. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol 2002; 168: 1578-82.
34. Ni Ni. Wen Wen. Yao Yao. et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 2005; 65: 9807-16.
35. Crispen Crispen. Uzzo Uzzo. Golovine Golovine. et al. Vitamin E succinate inhibits NF-κB and prevents the development of a metastatic phenotype in prostate cancer cells:implications for chemoprevention. Prostate 2007; 67: 582-90.
36. Hartman Hartman. Dorgan Dorgan. Woodson Woodson. et al. Effects of long-term α-tocopherol supplementation on serum hormones in older men. Prostate 2001; 46: 33-8.
37. Peters Peters. Littman Littman. Kristal Kristal. et al. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control 2008; 19: 75-87.
38. Lonn Lonn. Bosch Bosch. Yusuf Yusuf. et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a Randomized Controlled Trial. JAMA 2005; 293: 1338-47.
39. Lawson Lawson. Wright Wright. Subar Subar. et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007; 99: 754-64.
40. Satia-Abouta J. Patterson Patterson. King King. et al. Reliability and validity of self-report of vitamin and mineral supplement use in the Vitamins and Lifestyle Study. Am J Epidemiol 2003; 157: 944-54.
41. Li Li. Kantoff Kantoff. Giovannucci Giovannucci. et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005; 65: 2498-504.
42. van Gils CH. Bostick Bostick. Stern Stern. Taylor Taylor. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev 2002; 11: 1279-84.
43. Woodson Woodson. Tangrea Tangrea. Lehman Lehman. et al. Manganese superoxide dismutase (MnSOD) polymorphism, a-tocopherol supplementation and prostate cancer risk in the α-Tocopherol, β-Carotene Cancer Prevention Study (Finland). Cancer Causes Control 2003; 14: 513-8.
44. Goodman Goodman. Schaffer Schaffer. Omenn Omenn. Chen Chen. King King. The association between lung and prostate cancer risk, and serum micronutrients: results and Lessons learned from β-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 2003; 12: 518-26.
45. Cook Cook. Le Le. Manson Manson. Buring Buring. Hennekens Hennekens. Effects of β-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 2000; 11: 617-26.
46. Peters Peters. Leitzmann Leitzmann. Chatterjee Chatterjee. et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2007; 16: 962-8.